Search results

1. Dr Stephen McLaughlin

   ... Hsp90 directed anti-tumour drugs in development and clinical trials. ...

2. Dr Simon Pacey

   ... development, my research interests are: Early phase clinical trials (phase I/II) and Urological malignancy (prostate cancers). My projects ... proportion of investigator-led, locally sponsored clinical trials. Examples of open clinical trials include: Do Changes in ctDNA ...

3. Mr Samuel White

   ... actionable genomic results for patients enrolled on clinical trials and clinical studies led by researchers across the Centre.  CMDL ...

4. Dr Sujath Abbas

   ... DNA, envisioning its implementation in large scale clinical trials/screening. I have a Masters and a Bachelor’s degree in Biochemistry ...

5. Professor Tony Kouzarides

   ... MLL-leukaemia. This I-BET compound is currently in clinical trials. Tony is part of the Executive Board of the Cambridge Cancer Centre ...

6. Professor Vincent Gnanapragasam

   ... and completed numerous investigator led multicentre clinical trials including;  Predict Prostate RCT ,  PRIM biomarker ... studies). In recent years he has developed a new clinical trials programme exploring the concept of therapeutic intervention to slow or ...

7. Dr Will Ince

   ... All phase industry and investigator initiated clinical trials in renal, prostate and recurrent/metastatic head and neck cancer with ...

8. Dr Fengtong Ji

   I am concentrating on promoting developmental mechanics and microrobotic engineering, aiming at developing interdisciplinary paradigms to investigate the mechanical and physical mechanisms governing the embryonic development and morphogenetic...

9. Dr Rafael Romero Garcia

   Neurosurgical management of brain tumours has entered a new paradigm where resection is extended into the peri-tumoural margin to minimise ...

10. Dr Andrew Gee

    ... to cancer research is our work on ultrasound-guided radiotherapy and two- and three-dimensional elastography. ...

11. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity. ...

12. Dr Christopher Jones

    ... adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution. ...

13. Professor Charlotte Coles

    ... III randomised trial (RCT) investigating intensity modulated radiotherapy (IMRT) and partial breast radiotherapy in patients at low risk of recurrence – in follow up: 2018 ...

14. Ms Ceilidh Welsh

    ... toxicity data, from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...

15. Professor David Neal

    ... Principal Investigator on large clinical trial of surgery, radiotherapy and monitoring in early prostate cancer (NHS R&D funded - £36M). ...

16. Dr David Noble

    ... anatomy of head and neck cancer patients undergoing curative radiotherapy. This model will permit calculation of delivered radiation dose ... in the move towards increasingly adaptive and individualised radiotherapy. ...

17. Dr Francesca M. Cozzi

    ... in concert with genetic analyses to inform surgical and radiotherapy planning.  ...

18. Dr Gill Barnett

    ... the wide variation between patients in the severity of late radiotherapy toxicity. ...

19. Dr Henno Martin

    ... free DNA to discover markers of response and toxicity in radiotherapy for prostate and other cancers. ...

20. Dr Michael Boemo

    ... are pulsed into replicating DNA, they are incorporated into newly copied DNA by replication forks leaving a "footprint" of fork movement. ...

21. Dr John Lizhe Zhuang

    ... Barrett's oesophagus (BO). OAC is a lethal cancer often diagnosed at an advanced stage, and its incidence is increasing in Western ...

22. Dr Sarah Jefferies

    ... analysis and pseudo progression in patients treated for glioblastoma (T Booth, K Brindle; CRI) Collaborator in Gala 5 Study (CRUK grant ...

23. Miss Magda Gerigk

    ... working on developing microfluidic devices to mimic glioblastoma niches. ...

24. Dr Myriam Ouberai

    I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...

25. Mr Richard Mair

    ... interested in understanding the heterogeneity present within glioblastoma and how this can be understood through the development of novel ...

26. Miss Ye Liu

    My PhD project will be focused on glioblastoma, the most severe and deadly form of brain cancer; and the aim is ... space in order to measure migration/invasion abilities of glioblastoma cells. These cells are known to migrate along white matter tracts ... a physiologically relevant extracellular space within which glioblastoma cells can migrate and invade. Since our models are micron-scale, ...

Pages